CN104127782A - Traditional Chinese medicine composition for treating benign paroxysmal positional vertigo - Google Patents

Traditional Chinese medicine composition for treating benign paroxysmal positional vertigo Download PDF

Info

Publication number
CN104127782A
CN104127782A CN201410362638.XA CN201410362638A CN104127782A CN 104127782 A CN104127782 A CN 104127782A CN 201410362638 A CN201410362638 A CN 201410362638A CN 104127782 A CN104127782 A CN 104127782A
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
rhizoma
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410362638.XA
Other languages
Chinese (zh)
Inventor
高思山
李成君
王立珍
张茹
李江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410362638.XA priority Critical patent/CN104127782A/en
Publication of CN104127782A publication Critical patent/CN104127782A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a traditional Chinese medicine composition for treating benign paroxysmal positional vertigo. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicinal materials in parts by weight: 20-30 parts of poria cocos, 20-30 parts of tuber fleeceflower stem, 15-20 parts of rhizoma gastrodiae, 20-30 parts of white atractylodes rhizome, 20-30 parts of Chinese yam, 10-15 parts of rhizoma alismatis, 10-15 parts of dried orange peel, 10-15 parts of pinellia ternata, 20-30 parts of radix salviae miltiorrhizae, 20-30 parts of ligusticum chuanxiong, 20-30 parts of cortex albiziae, 10-15 parts of herba schizonepetae, 10-15 parts of radix saposhnikoviae, 10-15 parts of corn stigma, 10-15 parts of radix bupleuri, 20-30 parts of cistanche deserticola ma, 20-30 parts of fructus alpiniae oxyphyllae, and 6-10 parts of licorice. The selected traditional Chinese medicine raw materials are compatible by syndrome differentiation to together play the roles in excreting dampness to reduce phlegm, invigorating spleen and kidney, and calming heart and tranquilizing mind, and the traditional Chinese medicine composition has a remarkable curative effect on a patient with benign paroxysmal positional vertigo, has low recurrence rate, has no toxic or side effect, and is worthy of further promotion.

Description

A kind of Chinese medicine composition for the treatment of otolith disease
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of otolith disease.
Background technology
Otolith disease is called again Benign paroxysmal positional vertigo, there is positional, transience, repeatedly bring out the feature that fatigability, symptom show effect repeatedly, during outbreak marquis patient with looking thing rotation, feel sick, the symptom such as vomiting, profuse sweating, very painful, this disease is often seen in clinical.At present, adopt conventional western medicine, cure rate is low, relapse rate is high, and administration time has been grown and also had many untoward reaction.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition for the treatment of otolith disease.
The technology used in the present invention solution is:
Treat a Chinese medicine composition for otolith disease, it is that raw material of Chinese medicine by following weight portion proportioning is made: 20-30 parts, Poria, 20-30 parts of Caulis Polygoni Multiflori, 15-20 parts, Rhizoma Gastrodiae, 20-30 parts of the Rhizoma Atractylodis Macrocephalaes, 20-30 parts of Rhizoma Dioscoreaes, 10-15 parts of Rhizoma Alismatis, 10-15 parts of Pericarpium Citri Reticulataes, 10-15 parts of the Rhizoma Pinelliaes, 20-30 parts of Radix Salviae Miltiorrhizaes, 20-30 parts of Rhizoma Chuanxiongs, 20-30 parts of Cortex Albiziaes, 10-15 parts of Herba Schizonepetae, 10-15 parts of Radix Saposhnikoviaes, 10-15 parts of Stigma Maydis, 10-15 parts of Radix Bupleuri, 20-30 parts of Herba Cistanches, 20-30 parts of Fructus Alpiniae Oxyphyllae, 6-10 parts, Radix Glycyrrhizae.
Above-mentioned Chinese medicine composition can be prepared into decoction, and concrete steps are as follows:
The raw material of Chinese medicine of above-mentioned weight portion is put into drug-decocting appliance in the lump, add the clean water that meets drinking water standard, amount of water is advisable to surpass liquid level 2~3cm; Enter to decoct and front above-mentioned raw material of Chinese medicine is soaked to half an hour, make it fully moistening, fully fried in order to medicine juice; Then (suddenly) fire of useing force boils, then uses literary composition (micro-) fire instead and decoct.When decocting about 15 minutes, every dose stops while decocting into 180-200 milliliter medicine juice, removes medicinal residues, gets decoction.
Pharmacology of the present invention and effect are as follows:
Applicant is through clinical experience for many years, established and take the rule for the treatment of that eliminating dampness and resolving phlegm, invigorating spleen and kidney, mind tranquilizing and the heart calming be otolith disease, selected crude drug Poria, Caulis Polygoni Multiflori, Cortex Albiziae mind tranquilizing and the heart calming, dispelling wind and removing obstruction in the collateral in side, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong vital energy regualting and blood circulation-promoting are promoted blood circulation, Rhizoma Gastrodiae endogenous wind stopping relieving convulsion, Herba Schizonepetae, Radix Saposhnikoviae expelling pathogenic wind from the body surface, refresh oneself, Rhizoma Alismatis, Stigma Maydis eliminating dampness by diuresis, detumescence, Pericarpium Citri Reticulatae activating QI to eliminate phlegm, Rhizoma Pinelliae drying dampness to eliminate phlegm, the Rhizoma Atractylodis Macrocephalae, Rhizoma Dioscoreae spleen invigorating are regulated the flow of vital energy, Radix Bupleuri depressed liver-energy dispersing and QI regulating, Fructus Alpiniae Oxyphyllae, Herba Cistanches the kidney invigorating, Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription.Each raw material of Chinese medicine is played the effect of eliminating dampness and resolving phlegm, invigorating spleen and kidney, mind tranquilizing and the heart calming altogether through dialectical compatibility, evident in efficacy to otolith disease patient, and relapse rate is low, has no side effect, and clinic is further promoted.
Clinical data
1, basic document
Choosing 2012.01-2013.12 was gone to a doctor in the hospital of traditional Chinese hospital, Huangdao District, Qingdao of Shandong province department of Chinese medicine outpatient service otolith disease patient 100 examples, male's 52 examples, women's 48 examples, 45 years old mean age.All cases is all pressed otolith disease clinical diagnosis relevant criterion and is determined.
2, Therapeutic Method
Chinese medicine composition of the present invention is brewed into decoction as stated above, potion on the one, and a minute morning and evening takes, and within 7th, is 1 course for the treatment of, takes continuously 1 course for the treatment of.
3, efficacy determination
Concrete curative effect is divided following three grades: cure---and otolith disease symptom all disappears; Taking a turn for the better---otolith disease symptom obviously alleviates; Invalid---otolith disease symptom has no to disappear.
4, curative effect is summed up
Number of cases Cure Take a turn for the better Invalid Effective percentage
100 90 8 2 98%
Result shows, adopts decoction treatment otolith disease of the present invention, and cure rate and total effective rate are all higher, and therapeutic effect is remarkable, is worth further clinical expansion.And above-mentioned case patient is carried out to Long-term Clinical Observation discovery, and the patient after cured substance of the present invention only has 3 example recurrences, and the probability of recurrence is very low again.
The specific embodiment
Embodiment 1
Treat a Chinese medicine composition for otolith disease, it is that raw material of Chinese medicine by following weight proportion is made: Poria 20g, Caulis Polygoni Multiflori 30g, Rhizoma Gastrodiae 20g, Rhizoma Atractylodis Macrocephalae 20g, Rhizoma Dioscoreae 20g, Rhizoma Alismatis 10g, Pericarpium Citri Reticulatae 15g, Rhizoma Pinelliae 10g, Radix Salviae Miltiorrhizae 30g, Rhizoma Chuanxiong 20g, Cortex Albiziae 20g, Herba Schizonepetae 10g, Radix Saposhnikoviae 15g, Stigma Maydis 15g, Radix Bupleuri 10g, Herba Cistanches 20g, Fructus Alpiniae Oxyphyllae 30g, Radix Glycyrrhizae 6g.
Preparation method is as follows:
The raw material of Chinese medicine of above-mentioned weight portion is put into drug-decocting appliance in the lump, add the clean water that meets drinking water standard, amount of water is advisable to surpass liquid level 2~3cm; Enter to decoct and front above-mentioned raw material of Chinese medicine is soaked to half an hour, make it fully moistening, fully fried in order to medicine juice; Then (suddenly) fire of useing force boils, then uses literary composition (micro-) fire instead and decoct.When decocting about 15 minutes, every dose stops while decocting into 180-200 milliliter medicine juice, removes medicinal residues, gets decoction.
Embodiment 2
Treat a Chinese medicine composition for otolith disease, it is that raw material of Chinese medicine by following weight proportion is made: Poria 30g, Caulis Polygoni Multiflori 20g, Rhizoma Gastrodiae 15g, Rhizoma Atractylodis Macrocephalae 30g, Rhizoma Dioscoreae 30g, Rhizoma Alismatis 15g, Pericarpium Citri Reticulatae 10g, Rhizoma Pinelliae 15g, Radix Salviae Miltiorrhizae 20g, Rhizoma Chuanxiong 30g, Cortex Albiziae 30g, Herba Schizonepetae 15g, Radix Saposhnikoviae 10g, Stigma Maydis 10g, Radix Bupleuri 15g, Herba Cistanches 30g, Fructus Alpiniae Oxyphyllae 20g, Radix Glycyrrhizae 10g.
Preparation method is with embodiment 1.
Embodiment 3
Treat a Chinese medicine composition for otolith disease, it is that raw material of Chinese medicine by following weight proportion is made: Poria 25g, Caulis Polygoni Multiflori 25g, Rhizoma Gastrodiae 15g, Rhizoma Atractylodis Macrocephalae 25g, Rhizoma Dioscoreae 30g, Rhizoma Alismatis 12g, Pericarpium Citri Reticulatae 12g, Rhizoma Pinelliae 12g, Radix Salviae Miltiorrhizae 25g, Rhizoma Chuanxiong 25g, Cortex Albiziae 30g, Herba Schizonepetae 15g, Radix Saposhnikoviae 10g, Stigma Maydis 12g, Radix Bupleuri 15g, Herba Cistanches 30g, Fructus Alpiniae Oxyphyllae 20g, Radix Glycyrrhizae 8g.
Preparation method is with embodiment 1.

Claims (1)

1. treat a Chinese medicine composition for otolith disease, it is characterized in that it is that raw material of Chinese medicine by following weight portion proportioning is made: 20-30 parts, Poria, 20-30 parts of Caulis Polygoni Multiflori, 15-20 parts, Rhizoma Gastrodiae, 20-30 parts of the Rhizoma Atractylodis Macrocephalaes, 20-30 parts of Rhizoma Dioscoreaes, 10-15 parts of Rhizoma Alismatis, 10-15 parts of Pericarpium Citri Reticulataes, 10-15 parts of the Rhizoma Pinelliaes, 20-30 parts of Radix Salviae Miltiorrhizaes, 20-30 parts of Rhizoma Chuanxiongs, 20-30 parts of Cortex Albiziaes, 10-15 parts of Herba Schizonepetae, 10-15 parts of Radix Saposhnikoviaes, 10-15 parts of Stigma Maydis, 10-15 parts of Radix Bupleuri, 20-30 parts of Herba Cistanches, 20-30 parts of Fructus Alpiniae Oxyphyllae, 6-10 parts, Radix Glycyrrhizae.
CN201410362638.XA 2014-07-28 2014-07-28 Traditional Chinese medicine composition for treating benign paroxysmal positional vertigo Pending CN104127782A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410362638.XA CN104127782A (en) 2014-07-28 2014-07-28 Traditional Chinese medicine composition for treating benign paroxysmal positional vertigo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410362638.XA CN104127782A (en) 2014-07-28 2014-07-28 Traditional Chinese medicine composition for treating benign paroxysmal positional vertigo

Publications (1)

Publication Number Publication Date
CN104127782A true CN104127782A (en) 2014-11-05

Family

ID=51800804

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410362638.XA Pending CN104127782A (en) 2014-07-28 2014-07-28 Traditional Chinese medicine composition for treating benign paroxysmal positional vertigo

Country Status (1)

Country Link
CN (1) CN104127782A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104825589A (en) * 2015-04-23 2015-08-12 张先雷 Drug for treating otolithiasis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102283894A (en) * 2011-09-20 2011-12-21 荣成市商贸城卫生所 Traditional Chinese medicine composition for curing vertigo
CN102908604A (en) * 2012-11-11 2013-02-06 李承平 Bighead atractylodes rhizome and gastrodia tuer capsules
CN103800699A (en) * 2012-11-11 2014-05-21 郭以慧 Traditional Chinese medicine for treating dizziness

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102283894A (en) * 2011-09-20 2011-12-21 荣成市商贸城卫生所 Traditional Chinese medicine composition for curing vertigo
CN102908604A (en) * 2012-11-11 2013-02-06 李承平 Bighead atractylodes rhizome and gastrodia tuer capsules
CN103800699A (en) * 2012-11-11 2014-05-21 郭以慧 Traditional Chinese medicine for treating dizziness

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
周炜等: "许彭龄主任医师治疗肝阳上亢型眩晕经验", 《北京中医药大学学报(中医临床版)》 *
顾国龙等: "中药膏方在调治高血压病中的应用", 《中国中医药信息杂志》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104825589A (en) * 2015-04-23 2015-08-12 张先雷 Drug for treating otolithiasis

Similar Documents

Publication Publication Date Title
CN103860699B (en) A kind of pharmaceutical composition for effecting a radical cure three-hypers
CN103055116B (en) Traditional Chinese medicine composition for treating acnes
CN102512632B (en) Chinese herbal composition for treating abnormal menstruation
CN104013910A (en) Traditional Chinese medicine composition for treating hypertension
CN104043087A (en) Traditional Chinese medicine composition for treating Raynaud syndrome
CN102114230B (en) Medicament for treating psoriasis
CN102988616B (en) Chinese medicinal composition for treating anemia
CN105126045A (en) Traditional Chinese medicinal composition for treating climacteric syndrome
CN104173546A (en) Traditional Chinese medicine liquid for treating rhinitis
CN101757197A (en) Fumigating and washing medicine for treating hemorrhoids
CN102526635A (en) Medicament for treating premenstrual stress syndrome and preparation method thereof
CN102512647B (en) Chinese herbal composition for treating abdominal pain due to deficiency-cold
CN104623536A (en) Chinese medicinal combination for treating insomnia
CN104127782A (en) Traditional Chinese medicine composition for treating benign paroxysmal positional vertigo
CN103223139A (en) Traditional Chinese medicinal composition for treating chronic ulcerative colitis
CN102657816A (en) Medicament for treating dizziness and preparation method thereof
CN100542565C (en) A kind of Chinese medicine for oral administration for the treatment of cephalagra type hemihidrosis disease
CN104306534A (en) Traditional Chinese medicine medicated wine capable of nourishing kidney and tonifying yang and preparation method thereof
CN103751418A (en) Traditional Chinese medicine composition for treating restless leg syndrome
CN103830682A (en) Traditional Chinese medicine composition for treating liver depression and blood stasis syndromes
CN103735879A (en) Traditional Chinese medicine decoction for treating carotid artery plaque
CN103800838A (en) Traditional Chinese medicine composition for treating deficiency of the kidney-yin
CN103816403A (en) Chinese medicinal composition for treating syndrome of deficiency of liver blood
CN102416150B (en) Chinese medicinal composition for treating diarrhoea
CN103356962B (en) Traditional Chinese medicine composition for treating climacteric syndrome

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20141105

RJ01 Rejection of invention patent application after publication